| Literature DB >> 35260729 |
Yu Y Li1, Shams Rashid2, Jason Craft2, Yang J Cheng2, William Schapiro2, Kathleen Gliganic2, Ann-Marie Yamashita2, Marie Grgas2, Elizabeth Haag2, J Jane Cao2.
Abstract
Cardiac magnetic resonance imaging (MRI) has been largely dependent on retrospective cine for data acquisition. Real-time imaging, although inferior in image quality to retrospective cine, is more informative about motion dynamics. We herein developed a real-time cardiac MRI approach to temporospatial characterization of left ventricle (LV) and right ventricle (RV) wall motion. This approach provided two temporospatial indices, temporal periodicity and spatial coherence, for quantitative assessment of ventricular function. In a cardiac MRI study, we prospectively investigated temporospatial characterization in reference to standard volumetric measurements with retrospective cine. The temporospatial indices were found to be effective for evaluating the difference of ventricular performance between the healthy volunteers and the heart failure (HF) patients (LV temporal periodicity 0.24 ± 0.037 vs. 0.14 ± 0.021; RV temporal periodicity 0.18 ± 0.030 vs. 0.10 ± 0.014; LV spatial coherence 0.52 ± 0.039 vs. 0.38 ± 0.040; RV spatial coherence 0.50 ± 0.036 vs. 0.35 ± 0.035; all in arbitrary unit). The HF patients and healthy volunteers were well differentiated in the scatter plots of spatial coherence and temporal periodicity while they were mixed in those of end-systolic volume (ESV) and ejection fraction (EF) from volumetric measurements. This study demonstrated the potential of real-time cardiac MRI for intricate analysis of ventricular function beyond retrospective cine.Entities:
Mesh:
Year: 2022 PMID: 35260729 PMCID: PMC8904443 DOI: 10.1038/s41598-022-08094-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Diagnosed diseases and cardiac MRI assessment of the recruited HF patients.
| Patient ID | Diagnosed diseases | Cardiac MRI assessment | ||||
|---|---|---|---|---|---|---|
| LV | RV | |||||
| Type of HF | Other cardiovascular and pulmonary problems | Size | Systolic function | Size | Systolic function | |
| 1 | Chronic systolic | Nonischemic cardiomyopathy, shortness of breath, palpitation | Severely dilated, EDV index = 154 ml/m2 | Moderately reduced, EF = 37% | Normal, EDV index = 90 ml/m2 | Normal, EF = 56% |
| 2 | Chronic systolic | Hypertension, abnormal stress test | Moderately dilated, EDV index = 110 ml/m2 | Moderately reduced, EF = 42% | Normal, EDV index = 92 ml/m2 | Normal, EF = 57% |
| 3 | Acute systolic | Atrial fibrillation, stroke, cardiomyopathy, palpitation | Normal EDV index = 90 ml/m2 | Severely reduced, EF = 33% | Normal, EDV index = 76 ml/m2 | Mildly reduced, EF = 41% |
| 4 | Chronic diastolic | Hypertension, pulmonary hypertension, atrial fibrillation | Mildly dilated, EDV index = 104 ml/m2 | Normal, EF = 57% | Severely dilated, EDV index = 141 ml/m2 | Mildly reduced, EF = 42% |
| 5 | Chronic systolic | Hypertension, cardiomyopathy, chronic obstructive pulmonary disease | Normal, EDV index = 73 ml/m2 | Severely reduced, EF = 27% | Normal, EDV index = 72 ml/m2 | Moderately reduced, EF = 37% |
| 6 | Chronic systolic | Cardiomyopathy, paroxysmal atrial fibrillation | Normal, EDV index = 81 ml/m2 | Moderately reduced, EF = 39% | Normal, EDV index = 82 ml/m2 | Mildly reduced, EF = 43% |
| 7 | Acute on chronic systolic | Atrial fibrillation, stroke, nonischemic cardiomyopathy, transient ischemic attack, chest pain, palpitation | Normal, EDV index = 90 ml/m2 | Severely reduced, EF = 32% | Normal, EDV index = 90 ml/m2 | Mildly reduced, EF = 40% |
| 8 | Chronic diastolic | Nonischemic cardiomyopathy, atrial fibrillation | Normal, EDV index = 74 ml/m2 | Mildly reduced, EF = 46% | Normal, EDV index = 55 ml/m2 | Normal, EF = 51% |
| 9 | Acute on chronic systolic | Shortness of breath | Severely dilated, EDV index = 160 ml/m2 | Severely reduced, EF = 31% | Normal, EDV index = 90 ml/m2 | Moderately reduced, EF = 32% |
| 10 | Acute systolic | Restrictive cardiomyopathy, dyspnea on exertion, mitral valve prolapses, hypertension | Moderately dilated, EDV index = 114 ml/m2 | Moderately reduced, EF = 40% | Normal, EDV index = 67 ml/m2 | Normal, EF = 56% |
| 11 | Chronic diastolic | Pulmonary embolism, arteriosclerotic heart disease | Normal, EDV index = 72 ml/m2 | Normal, EF = 50% | Normal, EDV index = 66 ml/m2 | Mildly reduced, EF = 49% |
| 12 | Chronic systolic and diastolic | Premature ventricular contraction, atrioventricular block, left anterior fascicular block, hypertension, coronary artery disease, chest pain | Normal, EDV index = 98 ml/m2 | Moderately reduced, EF = 41% | Normal, EDV index = 67 ml/m2 | Normal, EF = 58% |
Figure 1(a) Selected time frames of the image examples from retrospective cine and real-time imaging in a resting-state healthy volunteer, an exercising-state volunteer, and a heart failure patient. (b) Bar plots of SNR and CNR measurements in retrospective cine and real-time images from different groups of the subjects. Each bar is presented as mean ± standard deviation (n = 12).
Summary (mean ± standard deviation) of the volumetric measurements with retrospective cine (RC) and real-time (RT) images and the measurement differences (DIFF) between two methods.
| Resting-state healthy volunteers (n = 12) | Exercising-state healthy volunteers (n = 12) | Resting-state HF patients (n = 12) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| RC | RT | DIFF | RC | RT | DIFF | RC | RT | DIFF | |
| LV-EDV (ml) | 149 ± 31 | 143 ± 28 | − 6.2 ± 5.7 | 148 ± 36 | 142 ± 27 | − 5.8 ± 10 | 213 ± 53 | 207 ± 48 | − 5.8 ± 7.9 |
| LV-ESV (ml) | 67 ± 17 | 59 ± 13 | − 7.8 ± 8.1 | 59 ± 22 | 50 ± 16 | − 8.3 ± 12 | 129 ± 40 | 122 ± 35 | − 6.1 ± 7.5 |
| LV-SV (ml) | 83 ± 16 | 84 ± 16 | 1.6 ± 5.8 | 90 ± 21 | 92 ± 13 | 2.4 ± 11 | 84 ± 25 | 84 ± 21 | 0.33 ± 6.7 |
| LV-EF (%) | 56 ± 4.2 | 59 ± 2.7 | 3.4 ± 4.4 | 61 ± 9.3 | 65 ± 5.3 | 4.0 ± 6.4 | 40 ± 8.4 | 41 ± 6.2 | 1.2 ± 3.2 |
| RV-EDV (ml) | 137 ± 32 | 130 ± 24 | − 6.8 ± 7.9 | 139 ± 42 | 134 ± 28 | − 4.6 ± 15 | 174 ± 62 | 171 ± 57 | − 3.0 ± 6.7 |
| RV-ESV (ml) | 53 ± 19 | 46 ± 12 | − 7.0 ± 7.4 | 46 ± 18 | 41 ± 14 | − 5.8 ± 10 | 94 ± 42 | 88 ± 39 | − 6.1 ± 3.6 |
| RV-SV (ml) | 84 ± 24 | 84 ± 18 | 0.25 ± 7.4 | 93 ± 29 | 94 ± 17 | − 1.2 ± 16 | 80 ± 26 | 83 ± 23 | 3.1 ± 4.5 |
| RV-EF (%) | 61 ± 9.7 | 64 ± 6.4 | 3.3 ± 4.7 | 67 ± 7.4 | 70 ± 5.2 | 3.4 ± 7.5 | 47 ± 8.7 | 50 ± 8.2 | 2.8 ± 1.7 |
Figure 2Box plots of the volumetric measurements with retrospective cine (a) and real-time imaging (b) in the healthy volunteers and HF patients. Each box provides the median, 25th and 75th percentiles of the measurements and the numbers give the t-test P values (n = 12).
Figure 3(a) Examples of reference wall-motion signals within LV-ROI (top row), and RV-ROI (bottom row). The unit on vertical axes is arbitrary. (b) Fourier transforms of the reference wall-motion signals in (a). The spectral magnitudes are normalized with respect to the zero-frequency component. The arrows indicate the cardiac frequency components for measuring temporal periodicity. (c) Box plots of the temporal periodicity measurements in real-time images from the healthy volunteers and HF patients. Each box provides the median, 25th and 75th percentiles of the measurements and the numbers give the mean ± standard deviation, and the t-test P values (n = 12).
Figure 4(a) Examples of correlation maps with spatial coherence measurements for LV and RV wall motion. (b) Box plots of spatial coherence measurements in real-time images from the healthy volunteers and HF patients. Each box provides the median, 25th and 75th percentiles of the measurements and the numbers give the mean ± standard deviation, and the t-test P values (n = 12).
Figure 5(a) Pearson correlation coefficients between temporospatial indices (temporal periodicity and spatial coherence) and volumetric indices (EDV, ESV, SV and EF) in LV and RV. (b) Scatter plots of volumetric indices (ESV vs. EF) and those of temporospatial indices (spatial coherence vs. temporal periodicity). The measurements in the healthy volunteers at rest and during exercise are represented respectively with “o” and “∇”, and those in the HF patients with “× ”.
Figure 6A diagram for temporospatial characterization with real-time cardiac MRI.